BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
Number Citing Articles
1 Prajapati KS, Gupta S, Kumar S. Targeting Breast Cancer-Derived Stem Cells by Dietary Phytochemicals: A Strategy for Cancer Prevention and Treatment. Cancers (Basel) 2022;14:2864. [PMID: 35740529 DOI: 10.3390/cancers14122864] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Saha S, D'souza D, Londhe VY. Exploring the concepts of various nano-formulations loaded with herbal drugs moieties against breast cancer using PRISMA analysis. Journal of Drug Delivery Science and Technology 2021;66:102865. [DOI: 10.1016/j.jddst.2021.102865] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Hakemi P, Ghadi A, Mahjoub S, Zabihi E, Tashakkorian H. Ratio Design of Docetaxel/Quercetin Co-Loading-to-Nanocarrier: Synthesis of PCL–PEG–PCL Copolymer, Study of Drug Release Kinetic and Growth Inhibition of Human Breast Cancer (MCF-7) Cell Line. Russ J Appl Chem 2021;94:388-401. [DOI: 10.1134/s1070427221030174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ciobanasu C. Peptides-based therapy and diagnosis. Strategies for non-invasive therapies in cancer. J Drug Target 2021;:1-17. [PMID: 33775187 DOI: 10.1080/1061186X.2021.1906885] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
5 Chiu HI, Samad NA, Fang L, Lim V. Cytotoxicity of targeted PLGA nanoparticles: a systematic review. RSC Adv 2021;11:9433-49. [PMID: 35423427 DOI: 10.1039/d1ra00074h] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
6 Das S, Das MK. Technological challenges of theranostics in oncology. Multifunctional Theranostic Nanomedicines in Cancer 2021. [DOI: 10.1016/b978-0-12-821712-2.00014-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 do Nascimento T, Tavares M, Monteiro MSSB, Santos-Oliveira R, Todeschini AR, de Souza VT, Ricci-Júnior E. Trends in Nanotechnology for in vivo Cancer Diagnosis: Products and Patents. Curr Pharm Des 2020;26:2167-81. [PMID: 32072890 DOI: 10.2174/1381612826666200219094853] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Norouzi M, Amerian M, Amerian M, Atyabi F. Clinical applications of nanomedicine in cancer therapy. Drug Discovery Today 2020;25:107-25. [DOI: 10.1016/j.drudis.2019.09.017] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 24.0] [Reference Citation Analysis]
9 Zheng G, Zheng M, Yang B, Fu H, Li Y. Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo. Biomed Pharmacother 2019;116:109006. [PMID: 31152925 DOI: 10.1016/j.biopha.2019.109006] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 15.3] [Reference Citation Analysis]
10 Awada H, Al Samad A, Laurencin D, Gilbert R, Dumail X, El Jundi A, Bethry A, Pomrenke R, Johnson C, Lemaire L, Franconi F, Félix G, Larionova J, Guari Y, Nottelet B. Controlled Anchoring of Iron Oxide Nanoparticles on Polymeric Nanofibers: Easy Access to Core@Shell Organic–Inorganic Nanocomposites for Magneto-Scaffolds. ACS Appl Mater Interfaces 2019;11:9519-29. [DOI: 10.1021/acsami.8b19099] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
11 Balan V, Malihin S, Verestiuc L. Chitosan-Based Systems for Theranostic Applications. Functional Chitosan 2019. [DOI: 10.1007/978-981-15-0263-7_12] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Chatzisideri T, Leonidis G, Sarli V. Cancer-targeted delivery systems based on peptides. Future Med Chem 2018;10:2201-26. [PMID: 30043641 DOI: 10.4155/fmc-2018-0174] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 6.5] [Reference Citation Analysis]
13 Azcona P, López-corral I, Lassalle V. Fabrication of folic acid magnetic nanotheranostics: An insight on the formation mechanism, physicochemical properties and stability in simulated physiological media. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2018;537:185-96. [DOI: 10.1016/j.colsurfa.2017.10.025] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
14 Avitabile E, Bedognetti D, Ciofani G, Bianco A, Delogu LG. How can nanotechnology help the fight against breast cancer? Nanoscale 2018;10:11719-31. [DOI: 10.1039/c8nr02796j] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 7.8] [Reference Citation Analysis]
15 Espinosa-cano E, Palao-suay R, Aguilar MR, Vázquez B, Román JS. Polymeric Nanoparticles for Cancer Therapy and Bioimaging. Nanooncology 2018. [DOI: 10.1007/978-3-319-89878-0_4] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
16 Khazeni S, Varamini P. Gonadotropin Releasing Hormone. Reference Module in Biomedical Sciences 2018. [DOI: 10.1016/b978-0-12-801238-3.98031-0] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Deda DK, Cardoso RM, Uchiyama MK, Pavani C, Toma SH, Baptista MS, Araki K. A reliable protocol for colorimetric determination of iron oxide nanoparticle uptake by cells. Anal Bioanal Chem 2017;409:6663-75. [DOI: 10.1007/s00216-017-0622-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
18 Xu WW, Liu DY, Cao YC, Wang XY. GE11 peptide-conjugated nanoliposomes to enhance the combinational therapeutic efficacy of docetaxel and siRNA in laryngeal cancers. Int J Nanomedicine 2017;12:6461-70. [PMID: 28919747 DOI: 10.2147/IJN.S129946] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
19 Elgqvist J. Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer. Int J Mol Sci 2017;18:E1102. [PMID: 28531102 DOI: 10.3390/ijms18051102] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 9.4] [Reference Citation Analysis]